Novo immediately threatened to sue, and then the FDA said that it plans to take decisive steps to limit access to the active ingredients in popular GLP-1 drugs like Wegovy, Ozempic and Zepbound
Thus, adding an additional commercially available drug, such as B12, is insufficient to justify compounding a GLP-1 medication
Most people with fatty liver have no symptoms whatsoever
Plenty of people with high BMIs are also healthy
The early concern that GLP-1 causes thyroid cancer has lead to extensive investigations and studies looking at this issues and to date there has been nothing to suggest a concern despite millions of people being treated with GLP-1 therapies around the world
This is somewhat unsurprising, given the fact that persistently elevated androgen levels in PWA rodents have been shown to prevent ovulatory rescue after administration of more proxy activators of the reproductive axis, such as kisspeptin 46